Major Advances in the Treatment of Cancer What does a Non-Oncologist need to know?

Journal Title: Sultan Qaboos University Medical Journal - Year 2008, Vol 8, Issue 2

Abstract

Te last few years have seen major advances in the management of cancers. Since it is not possible for the non-oncologist to keep abreast with the latest developments in the field of oncology, this review summarises the most significant advances in the area of treatment of various cancers over the past four years. In some areas, a paradigm shift has occurred setting new standards of care, for example, the use of targeted therapy (trastuzumab) in adjuvant treatment of breast cancer; the use of monoclonal antibodies (rituximab), with or without chemotherapy, in the treatment and maintenance of indolent lymphoma; the use of the tyrosine kinase inhibitor, imatinib, in the adjuvant setting in resected gastrointestinal stromal tumours. In other areas, new treatments have emerged, such as, the use of targeted therapies in hepatocellular carcinoma (sorafenib) and renal cell carcinoma (sunitinib, sorafenib, temsirolimus, bevacizumab). In some other cancers, the addition of targeted therapies has improved survival rates, for example, in colon cancer (bevacizumab, cetuximb, panitumumab), head and neck cancers (cetuximab), and pancreatic adenocarcinoma (erlotinib). In yet another group, new targeted therapies have emerged where resistance was previously observed with the existing targeted therapies, for example, breast cancer (lapatinib), chronic myeloid leukemia (dasatinib). Finally, the addition of chemotherapeutic agents has improved survival in some forms of cancer, for example, oxaliplatin in adjuvant treatment of colon cancer, temozolamide in glioblastoma multiforme, and adjuvant chemotherapy in non-small cell lung cancer. Te information summarized here may provide useful for the busy physician needing an update in the field of oncology.

Authors and Affiliations

Ikram A Burney| Department of Medicine, Sultan Qaboos University, Muscat, Oman, Mansour S Al-Moundhri| Department of Medicine, Sultan Qaboos University, Muscat, Oman

Keywords

Related Articles

A Study of Post-Caesarean Section Wound Infections in a Regional Referral Hospital, Oman

Objectives: Te aim of this study was to determine the incidence of surgical site infections (SSI) in patients undergoing a Caesarean section (CS) and to identify risk factors, common bacterial pathogens and antibiotic...

A Massive Tuberculosis Abscess at the Erector Spinae Muscles and Subcutaneous Tissues in a Young Man

Tuberculosis (TB) is a chronic granulomatous infection which can present in an atypical form. Isolated muscle involvement is very rare. We report a 25-year-old man who presented with a massive cystic swelling on the ri...

Students’ Perceived Benefits of Integrating a BSc in Health Sciences within a Medical Degree at Sultan Qaboos University

Objectives: After completing the pre-clinical phase of a Doctor of Medicine (MD) curriculum, undergraduate medical students may choose to add a Bachelor of Science (BSc) degree in health sciences to their MD degree. Limi...

A Retrospective Study of Fungal Corneal Ulcers in the South Sharqiyah Region in Oman

To study the incidence, identify the risk factors and determine the predominant microorganisms and treatment regimen of fungal corneal ulcers. Methods: Tis was a retrospective analysis of corneal ulcers treated in the Op...

Impact of Geographical Proximity on Health Care Seeking Behaviour in Northern Oman

Despite its impact on health policy, the relationship between geographical proximity and health care seeking has received scant attention in the medical literature. Tis paper aims to evaluate the relationship between ge...

Download PDF file
  • EP ID EP13794
  • DOI -
  • Views 304
  • Downloads 13

How To Cite

Ikram A Burney, Mansour S Al-Moundhri (2008). Major Advances in the Treatment of Cancer What does a Non-Oncologist need to know?. Sultan Qaboos University Medical Journal, 8(2), 137-148. https://europub.co.uk/articles/-A-13794